| Jennifer Mckay, MD | |
|
1325 S Cliff Ave, Sioux Falls, SD 57105-1007 | |
| (605) 322-7905 | |
| (605) 322-8414 |
| Full Name | Jennifer Mckay |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 1325 S Cliff Ave, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407891716 | NPI | - | NPPES |
| 6004563 | Medicaid | SD | |
| 1566000 | Medicaid | IA | |
| 5189 | Other | SD | DAKOTACARE |
| 0041603 | Other | SD | SD BLUE CROSS |
| 200960900 | Medicaid | MN | |
| 164K0MC | Other | MN | MN BLUE CROSS BS |
| 46022474331 | Medicaid | NE | |
| 6004564 | Medicaid | SD | |
| P00068515 | Other | SD | RR MEDICARE |
| 6004562 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 5189 (South Dakota) | Primary |
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that U.S. and European (France, Germany, Italy, Spain and U.K.) sales of Roche/Biogen Idec's Rituxan/MabThera, Bristol-Myers Squibb/Merck's Erbitux and Roche's Herceptin will peak at almost $16 billion in 2014, before falling to roughly $10 billion in 2018.
The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
The shortage of available organs for transplantation has driven up use of high-risk donor livers. New research published in the October issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases, reported that high volume transplant centers more frequently utilized livers with a high donor risk index, but achieved better risk-adjusted graft and recipient survival rates compared with lower volume centers.
The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks.
Animals have an innate preference for certain scents and tastes. Attractive scents are linked to things like good food.
› Verified 4 days ago
| Entity Name | Avera Queen Of Peace |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205359031 PECOS PAC ID: 9335050806 Enrollment ID: O20031229000301 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that U.S. and European (France, Germany, Italy, Spain and U.K.) sales of Roche/Biogen Idec's Rituxan/MabThera, Bristol-Myers Squibb/Merck's Erbitux and Roche's Herceptin will peak at almost $16 billion in 2014, before falling to roughly $10 billion in 2018.
The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
The shortage of available organs for transplantation has driven up use of high-risk donor livers. New research published in the October issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases, reported that high volume transplant centers more frequently utilized livers with a high donor risk index, but achieved better risk-adjusted graft and recipient survival rates compared with lower volume centers.
The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks.
Animals have an innate preference for certain scents and tastes. Attractive scents are linked to things like good food.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Mckay, MD Po Box 86370, Sioux Falls, SD 57118-6370 Ph: (605) 322-7510 | Jennifer Mckay, MD 1325 S Cliff Ave, Sioux Falls, SD 57105-1007 Ph: (605) 322-7905 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that U.S. and European (France, Germany, Italy, Spain and U.K.) sales of Roche/Biogen Idec's Rituxan/MabThera, Bristol-Myers Squibb/Merck's Erbitux and Roche's Herceptin will peak at almost $16 billion in 2014, before falling to roughly $10 billion in 2018.
The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
The shortage of available organs for transplantation has driven up use of high-risk donor livers. New research published in the October issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases, reported that high volume transplant centers more frequently utilized livers with a high donor risk index, but achieved better risk-adjusted graft and recipient survival rates compared with lower volume centers.
The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks.
Animals have an innate preference for certain scents and tastes. Attractive scents are linked to things like good food.
› Verified 4 days ago
Dr. Troy Adam Rowekamp, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-7645 Fax: 605-322-8414 | |
David Kent Nussbaum, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-7905 Fax: 605-322-8414 | |
Dr. Vishnu Kanala, M.B.B.S. Hospitalist Medicare: Medicare Enrolled Practice Location: 1600 W 22nd St, Sioux Falls, SD 57105 Phone: 605-312-1000 Fax: 605-312-1001 | |
Bhargavi Ghanta, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1305 W 18th St, Sioux Falls, SD 57105 Phone: 605-328-4973 | |
Dr. Tamera Lee Sturm, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-7905 Fax: 605-322-8414 | |
Dr. Uma Maheswara Rao Motapothula, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1305 W 18th St, Sioux Falls, SD 57105 Phone: 605-328-4973 | |
Sassen S Kwasa, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1400 W 22nd St, Sioux Falls, SD 57105 Phone: 605-357-1300 |